Crossmark Global Holdings’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.4M Sell
87,490
-5,052
-5% -$543K 0.15% 165
2025
Q1
$9.34M Sell
92,542
-1,028
-1% -$104K 0.16% 156
2024
Q4
$8.36M Sell
93,570
-517
-0.5% -$46.2K 0.15% 160
2024
Q3
$7.89M Buy
94,087
+1,456
+2% +$122K 0.14% 177
2024
Q2
$7.13M Sell
92,631
-2,259
-2% -$174K 0.14% 173
2024
Q1
$6.5M Sell
94,890
-1,324
-1% -$90.7K 0.12% 191
2023
Q4
$5.56M Sell
96,214
-538
-0.6% -$31.1K 0.12% 204
2023
Q3
$5.21M Sell
96,752
-1,430
-1% -$76.9K 0.12% 204
2023
Q2
$5.08M Buy
98,182
+2,347
+2% +$121K 0.11% 218
2023
Q1
$4.79M Sell
95,835
-1,973
-2% -$98.7K 0.11% 219
2022
Q4
$4.53M Buy
97,808
+4,995
+5% +$231K 0.11% 216
2022
Q3
$3.59M Sell
92,813
-363
-0.4% -$14.1K 0.1% 230
2022
Q2
$3.47M Buy
93,176
+280
+0.3% +$10.4K 0.09% 253
2022
Q1
$4.11M Buy
92,896
+1,232
+1% +$54.6K 0.09% 236
2021
Q4
$3.89M Sell
91,664
-14,777
-14% -$628K 0.08% 239
2021
Q3
$4.62M Buy
106,441
+13,255
+14% +$575K 0.11% 206
2021
Q2
$3.99M Buy
93,186
+2,784
+3% +$119K 0.09% 228
2021
Q1
$3.49M Sell
90,402
-3,367
-4% -$130K 0.09% 245
2020
Q4
$3.37M Sell
93,769
-168
-0.2% -$6.04K 0.09% 261
2020
Q3
$3.59M Sell
93,937
-1,135
-1% -$43.4K 0.1% 219
2020
Q2
$3.34M Sell
95,072
-2,210
-2% -$77.6K 0.1% 235
2020
Q1
$3.17M Buy
97,282
+1,279
+1% +$41.7K 0.11% 204
2019
Q4
$4.34M Sell
96,003
-21,269
-18% -$962K 0.12% 198
2019
Q3
$4.77M Sell
117,272
-4,671
-4% -$190K 0.14% 178
2019
Q2
$5.24M Sell
121,943
-2,775
-2% -$119K 0.15% 173
2019
Q1
$4.79M Buy
124,718
+284
+0.2% +$10.9K 0.14% 187
2018
Q4
$4.4M Sell
124,434
-10,503
-8% -$371K 0.14% 183
2018
Q3
$5.2M Sell
134,937
-6,461
-5% -$249K 0.13% 193
2018
Q2
$4.62M Sell
141,398
-4,790
-3% -$157K 0.12% 199
2018
Q1
$3.99M Sell
146,188
-9,359
-6% -$256K 0.1% 238
2017
Q4
$3.86M Buy
155,547
+137
+0.1% +$3.4K 0.09% 268
2017
Q3
$4.53M Buy
+155,410
New +$4.53M 0.12% 211
2016
Q3
$4.53M Buy
+155,410
New +$4.53M 0.12% 211